Tri Chemical Laboratories (TSE:4369) EBIT: 円7,986 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4369 Tri Chemical Laboratories Inc TSE:4369
88 GF Score
Price 円3,190.00
GF Value 円5,112.01
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Tri Chemical Laboratories EBIT?

Tri Chemical Laboratories TSE:4369 -6.45% 88 EBIT is 円7,986 Mil as of Apr. 2026. GuruFocus rates TSE:4369 with a GF Score™ of 88/100 and a GF Value™ of 円5,112.01 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Tri Chemical Laboratories's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2026 was 円2,508 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2026 was 円7,986 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Tri Chemical Laboratories's annualized ROC % for the quarter that ended in Apr. 2026 was 17.23%. Tri Chemical Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 36.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Tri Chemical Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 7.84%.


Tri Chemical Laboratories  (TSE:4369) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Tri Chemical Laboratories's annualized ROC % for the quarter that ended in Apr. 2026 is calculated as:

ROC % (Q: Apr. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2026 ) + Invested Capital (Q: Apr. 2026 ))/ count )
=8276.356 * ( 1 - 25.35% )/( (34192.54 + 37525.42)/ 2 )
=6178.299754/35858.98
=17.23 %

where

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=47274.965 - 5802.447 - ( 7279.978 - max(0, 7604.585 - 23253.287+7279.978))
=34192.54

Invested Capital(Q: Apr. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=47174.129 - 1850.782 - ( 7797.927 - max(0, 4849.93 - 22698.801+7797.927))
=37525.42

Note: The Operating Income data used here is four times the quarterly (Apr. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Tri Chemical Laboratories's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2026  Q: Apr. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=10032.004/( ( (17225.32 + max(9131.605, 0)) + (17490.553 + max(10872.384, 0)) )/ 2 )
=10032.004/( ( 26356.925 + 28362.937 )/ 2 )
=10032.004/27359.931
=36.67 %

where Working Capital is:

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4441.035 + 7865.893 + 3666.381) - (5802.447 + 0 + 1039.257)
=9131.605

Working Capital(Q: Apr. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4146.985 + 7065.984 + 3687.905) - (1850.782 + 0 + 2177.708)
=10872.384

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Tri Chemical Laboratories's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2026 )
=7986.353/101829.609
=7.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tri Chemical Laboratories EBIT Related Terms


Tri Chemical Laboratories EBIT Historical Data

* Premium members only.

The historical data trend for Tri Chemical Laboratories's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tri Chemical Laboratories EBIT Chart

Tri Chemical Laboratories Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,326.83 6,214.95 3,300.44 6,607.00 7,124.63

Tri Chemical Laboratories Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,646.28 2,166.57 1,665.28 1,646.51 2,508.00

TSE:4369 vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, Tri Chemical Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tri Chemical Laboratories EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tri Chemical Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tri Chemical Laboratories's EV-to-EBIT falls into.


TSE:4369
88GF Score
Tri Chemical Laboratories Inc TSE:4369
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tri Chemical Laboratories EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7,986 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円7,986 Mil mean?
Tri Chemical Laboratories (TSE:4369) has a EBIT of 円7,986 Mil as of Apr. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tri Chemical Laboratories.
Is Tri Chemical Laboratories' EBIT too high?
Tri Chemical Laboratories' current EBIT is 円7,986 Mil. Overall, Tri Chemical Laboratories has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tri Chemical Laboratories' EBIT compare to LIN and SHW?
Tri Chemical Laboratories' EBIT of 円7,986 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tri Chemical Laboratories. Tri Chemical Laboratories's current EBIT is 円7,986 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tri Chemical Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Tri Chemical Laboratories (TSE:4369) is currently considered Significantly Undervalued. The stock's GF Value™ is 円5,112.01, compared to a current price of 円3,190.00 — trading 37.6% below its estimated fair value. The current EBIT is 円7,986 Mil. Tri Chemical Laboratories' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Tri Chemical Laboratories (TSE:4369), the current EBIT is 円7,986 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tri Chemical Laboratories (TSE:4369) Overvalued in 2026?

Based on GuruFocus' analysis, Tri Chemical Laboratories stock appears to be undervalued. The current stock price of 円3,190.00 is trading 37.6% below its estimated GF Value™ of 円5,112.01. GuruFocus considers Tri Chemical Laboratories to be Significantly Undervalued.

Key valuation signals for TSE:4369:

  • EBIT: 円7,986 Mil
  • GF Value™: 円5,112.01 vs. price of 円3,190.00 (37.6% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the TSE:4369 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tri Chemical Laboratories Business Description

Other Exchanges 22E:Germany
Address 8154-217 Uenohara, Uenohara-shi, Yamanashi, JPN, 409-0112
Tri Chemical Laboratories Inc is engaged in the manufacturing of high-purity chemical compounds for the semiconductor industry.
88GF Score

Get the complete analysis for TSE:4369

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,190.00
Price
円5,112.01
GF Value